Clinical Trial Update: The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluating the myocardial protective effects of a moderate-potassium blood cardioplegia solution in pediatric cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Moderate-potassium blood cardioplegia (potassium-based blood cardioplegia solution)

Snippet

Sponsor: Xijing Hospital | Conditions: Congenital Heart Disease | NA | Status: COMPLETED